生命信息与支持产线产品
Search documents
迈瑞医疗(300760):国际业务增长稳健,第四季度营收同比增长有望提速
Guoxin Securities· 2025-11-06 11:28
证券研究报告 | 2025年11月06日 迈瑞医疗(300760.SZ) 优于大市 | 盈利预测和财务指标 | 2023 | 2024 | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业收入(百万元) | 34,932 | 36,726 | 34,954 | 38,844 | 43,856 | | (+/-%) | 15.0% | 5.1% | -4.8% | 11.1% | 12.9% | | 净利润(百万元) | 11582 | 11668 | 9879 | 11153 | 13129 | | (+/-%) | 20.6% | 0.7% | -15.3% | 12.9% | 17.7% | | 每股收益(元) | 9.55 | 9.62 | 8.15 | 9.20 | 10.83 | | EBIT Margin | 34.6% | 33.3% | 31.9% | 32.4% | 33.9% | | 净资产收益率(ROE) | 35.0% | 32.5% | 25.1% | 25.8% | 27.5% | | 市盈率(PE ...